465 related articles for article (PubMed ID: 29669333)
1. The Role of Proteasome Inhibitor MG132 in 2,4-Dinitrofluorobenzene-Induced Atopic Dermatitis in NC/Nga Mice.
Ohkusu-Tsukada K; Ito D; Takahashi K
Int Arch Allergy Immunol; 2018; 176(2):91-100. PubMed ID: 29669333
[TBL] [Abstract][Full Text] [Related]
2. Rosmarinic acid attenuates 2,4-dinitrofluorobenzene-induced atopic dermatitis in NC/Nga mice.
Jang AH; Kim TH; Kim GD; Kim JE; Kim HJ; Kim SS; Jin YH; Park YS; Park CS
Int Immunopharmacol; 2011 Sep; 11(9):1271-7. PubMed ID: 21504802
[TBL] [Abstract][Full Text] [Related]
3. Topical application of aloperine improves 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice.
Yuan XY; Ma HM; Li RZ; Wang RY; Liu W; Guo JY
Eur J Pharmacol; 2011 May; 658(2-3):263-9. PubMed ID: 21371468
[TBL] [Abstract][Full Text] [Related]
4. Oral administration of Uncariae rhynchophylla inhibits the development of DNFB-induced atopic dermatitis-like skin lesions via IFN-gamma down-regulation in NC/Nga mice.
Kim DY; Jung JA; Kim TH; Seo SW; Jung SK; Park CS
J Ethnopharmacol; 2009 Apr; 122(3):567-72. PubMed ID: 19429328
[TBL] [Abstract][Full Text] [Related]
5. The histone deacetylase inhibitor, trichostatin A, inhibits the development of 2,4-dinitrofluorobenzene-induced dermatitis in NC/Nga mice.
Kim TH; Jung JA; Kim GD; Jang AH; Cho JJ; Park YS; Park CS
Int Immunopharmacol; 2010 Oct; 10(10):1310-5. PubMed ID: 20728595
[TBL] [Abstract][Full Text] [Related]
6. The inhibitory effect of naringenin on atopic dermatitis induced by DNFB in NC/Nga mice.
Kim TH; Kim GD; Ahn HJ; Cho JJ; Park YS; Park CS
Life Sci; 2013 Oct; 93(15):516-24. PubMed ID: 23933131
[TBL] [Abstract][Full Text] [Related]
7. α-Lipoic acid suppresses the development of DNFB-induced atopic dermatitis-like symptoms in NC/Nga mice.
Kim GD; Kim TH; Jang AH; Ahn HJ; Park YS; Park CS
Exp Dermatol; 2011 Feb; 20(2):97-101. PubMed ID: 21166725
[TBL] [Abstract][Full Text] [Related]
8. Oral administration of Astragalus membranaceus inhibits the development of DNFB-induced dermatitis in NC/Nga mice.
Lee SJ; Oh SG; Seo SW; Ahn HJ; Geum D; Cho JJ; Park CS
Biol Pharm Bull; 2007 Aug; 30(8):1468-71. PubMed ID: 17666805
[TBL] [Abstract][Full Text] [Related]
9. Omega-3 fatty acid-derived mediator, Resolvin E1, ameliorates 2,4-dinitrofluorobenzene-induced atopic dermatitis in NC/Nga mice.
Kim TH; Kim GD; Jin YH; Park YS; Park CS
Int Immunopharmacol; 2012 Dec; 14(4):384-91. PubMed ID: 22951188
[TBL] [Abstract][Full Text] [Related]
10. Hyperresponsive TH2 cells with enhanced nuclear factor-kappa B activation induce atopic dermatitis-like skin lesions in Nishiki-nezumi Cinnamon/Nagoya mice.
Tenda Y; Yamashita M; Kimura MY; Hasegawa A; Shimizu C; Kitajima M; Onodera A; Suzuki A; Seki N; Nakayama T
J Allergy Clin Immunol; 2006 Sep; 118(3):725-33. PubMed ID: 16950294
[TBL] [Abstract][Full Text] [Related]
11. Melatonin inhibits the development of 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice.
Kim TH; Jung JA; Kim GD; Jang AH; Ahn HJ; Park YS; Park CS
J Pineal Res; 2009 Nov; 47(4):324-9. PubMed ID: 19817972
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive effects of fisetin against dinitrofluorobenzene-induced atopic dermatitis-like symptoms in NC/Nga mice.
Kim GD; Lee SE; Park YS; Shin DH; Park GG; Park CS
Food Chem Toxicol; 2014 Apr; 66():341-9. PubMed ID: 24525099
[TBL] [Abstract][Full Text] [Related]
13. Repeated topical challenge with chemical antigen elicits sustained dermatitis in NC/Nga mice in specific-pathogen-free condition.
Tomimori Y; Tanaka Y; Goto M; Fukuda Y
J Invest Dermatol; 2005 Jan; 124(1):119-24. PubMed ID: 15654964
[TBL] [Abstract][Full Text] [Related]
14. Capsiate Inhibits DNFB-Induced Atopic Dermatitis in NC/Nga Mice through Mast Cell and CD4+ T-Cell Inactivation.
Lee JH; Lee YS; Lee EJ; Lee JH; Kim TY
J Invest Dermatol; 2015 Aug; 135(8):1977-1985. PubMed ID: 25806854
[TBL] [Abstract][Full Text] [Related]
15. Mechanism underlying the effect of combined therapy using glucosamine and low-dose cyclosporine A on the development of atopic dermatitis-like skin lesions in NC/Nga mice.
Kim CH; Choi YS; Cheong KA; Lee AY
Int Immunopharmacol; 2013 Feb; 15(2):424-32. PubMed ID: 23352844
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of 2,4-dinitrofluorobenzene-induced atopic dermatitis by topical application of the butanol extract of Cordyceps bassiana in NC/Nga mice.
Wu G; Li L; Sung GH; Kim TW; Byeon SE; Cho JY; Park CW; Park HJ
J Ethnopharmacol; 2011 Mar; 134(2):504-9. PubMed ID: 21184821
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of Solanum tuberosum L. var. vitelotte extract on 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice.
Shim EH; Choung SY
J Pharm Pharmacol; 2014 Sep; 66(9):1303-16. PubMed ID: 24961480
[TBL] [Abstract][Full Text] [Related]
18. Hyperproduction of IFN-gamma by CpG oligodeoxynucleotide-induced exacerbation of atopic dermatitis-like skin lesion in some NC/Nga mice.
Takakura M; Takeshita F; Aihara M; Xin KQ; Ichino M; Okuda K; Ikezawa Z
J Invest Dermatol; 2005 Dec; 125(6):1156-62. PubMed ID: 16354185
[TBL] [Abstract][Full Text] [Related]
19. Effects of topically applied rapamycin and mycophenolic acid on TNCB-induced atopic dermatitis-like skin lesions in NC/Nga mice.
Jung KE; Lee YJ; Ryu YH; Kim JE; Kim HS; Kim BJ; Kang H; Park YM
Int Immunopharmacol; 2015 Jun; 26(2):432-8. PubMed ID: 25794646
[TBL] [Abstract][Full Text] [Related]
20. Immune response against 2,4-dinitrofluorobenzene-induced atopic dermatitis-like clinical manifestation is suppressed by spermidine in NC/Nga mice.
Kim GD; Kim TH; Park YS; Ahn HJ; Cho JJ; Park CS
Scand J Immunol; 2015 Apr; 81(4):221-8. PubMed ID: 25645543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
